Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

類似資料

• Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors
  著者:: Pires, Eusebio S., 等
  出版事項: (2017)
• SAS1B Protein [Ovastacin] Shows Temporal and Spatial Restriction to Oocytes in Several Eutherian Orders and Initiates Translation at the Primary to Secondary Follicle Transition
  著者:: Pires, Eusebio S, 等
  出版事項: (2013)
• Oocyte specific oolemmal SAS1B involved in sperm binding through intra-acrosomal SLLP1 during fertilization
  著者:: Sachdev, Monika, 等
  出版事項: (2011)
• Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer
  著者:: Knapp, Kiley A., 等
  出版事項: (2018)
• Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads
  著者:: Lussier, Danielle M., 等
  出版事項: (2021)